Ovarian Cancer Test Not Worth Risk, Advisory Panel Says

Healthy women shouldn’t take screening tests to spot ovarian cancer, a U.S. panel said, updating and reaffirming its 2004 recommendation against the procedure.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.